BioFactura Overview

  • Founded
  • 2004
Founded
  • Status
  • Private
  • Employees
  • 15
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $6M
Latest Deal Amount
  • Investors
  • 12

BioFactura General Information

Description

Developer of a biomanufacturing platform designed for biodefense vaccines and biological drugs. The company's platform is a novel system to rapidly generate stable NS0 cell lines for biopharmaceutical which include cholesterol-free production medium and pre-adapted parental cells, modular expression vectors that utilize patented multiplexed selection technology, enabling physicians to commercializes products to market with faster, lower cost at superior-quality.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 8435 Progress Drive
  • Suite Z
  • Frederick, MD 21701
  • United States
+1 (301) 000-0000

BioFactura Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BioFactura Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Corporate (Series B) 29-Apr-2019 $6M 00.000 Completed Generating Revenue
8. Grant 01-Jan-2018 00000 00.000 Completed Generating Revenue
7. Angel (individual) 26-Apr-2016 00.000 00.000 Completed Generating Revenue
6. Grant 07-Apr-2016 0000 0000 Completed Generating Revenue
5. Accelerator/Incubator 04-Sep-2015 0000 Completed Generating Revenue
4. Grant 15-Sep-2014 0000 Completed Generating Revenue
3. Grant 26-Jun-2012 00.000 0000 Completed Generating Revenue
2. Accelerator/Incubator 31-Jan-2006 $25K $25K Completed Generating Revenue
1. Grant 01-Jan-2006 $3.07M Completed Generating Revenue
To view BioFactura’s complete valuation and funding history, request access »

BioFactura Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a biomanufacturing platform designed for biodefense vaccines and biological drugs. The company's platform i
Drug Discovery
Frederick, MD
15 As of 2019
00.000
00000000000 00.000

00000

la pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt moll
0000000000000
Cambridge, United Kingdom
000 As of 0000
00000
0000 0000-00-00
0000000000 0 00000

00000 00

velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident,
000000000000000
Oxfordshire, United Kingdom
00 As of 0000
00000
00.00 0000-00-00
0000000000 0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioFactura Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kymab Venture Capital-Backed Cambridge, United Kingdom 000 00000 0000000000 0 00000
00000 000000000000 Venture Capital-Backed Oxfordshire, United Kingdom 00 00000 0000000000 0 00000
0000000 0000000000 Formerly VC-backed Cambridge, United Kingdom 00 00000 000000000 00000
00000 000000000000 Venture Capital-Backed Boston, MA 00 0000 00000000000 0000
00000000 Corporation Austin, TX 00 0000 00000000 0000
You’re viewing 5 of 12 competitors. Get the full list »

BioFactura Executive Team (4)

Name Title Board Seat Contact Info
Darryl Sampey Ph.D Chief Executive Officer, President, Board Member, Chief Scientific Officer and Co-Founder
Alex DeSeabra Co-founder, Board Member & Consultant
Jeffrey Hausfeld MD Chief Medical Officer & Chairman
To view BioFactura’s complete executive team members history, request access »

BioFactura Board Members (4)

Name Representing Role Since
Alex DeSeabra BioFactura Co-founder, Board Member & Consultant 000 0000
Darryl Sampey Ph.D BioFactura Chief Executive Officer, President, Board Member, Chief Scientific Officer and Co-Founder 000 0000
Jeffrey Hausfeld MD BioFactura Chief Medical Officer & Chairman 000 0000
To view BioFactura’s complete board members history, request access »

BioFactura Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioFactura Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
University Of Vermont Health Network Corporation Minority 000 0000 000000 0
Wilson Sonsini Goodrich & Rosati Corporation Minority 000 0000 000000 0
Jeffrey Hausfeld Angel (individual) Minority 000 0000 000000 0
Maryland Department of Commerce Government 000 0000 000000 0
St. Louis Development Lender/Debt Provider Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »